Keywords: japan, urges, development, pfizer, lyrica, consider, normosang

Japan urges development of Pfizer's Lyrica and will consider Normosang and Yondelis

Article | 04 February 2008

Print This

The Study Committee on the Use of Unapproved Drugs within Japan's Ministry of Health, Labor and Welfare has recently decided ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in